| Stage | V | % of rev | EXLS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $11.6B | 100.00% | $634M | 100.00% | V ×18.35 |
| Gross profit | $9.2B | 78.87% | $241M | 38.04% | V +40.8pp |
| Operating income | $6.9B | 59.12% | $89M | 14.02% | V +45.1pp |
| Pre-tax income | $6.8B | 58.74% | $87M | 13.67% | V +45.1pp |
| Net income | $5.6B | 48.38% | $69M | 10.85% | V +37.5pp |
| Stage | V | EXLS | Gap · A − B |
|---|---|---|---|
| Revenue | $11.6B100.00% | $634M100.00% | V ×18.35 |
| Gross profit | 78.87%$9.2B | 38.04%$241M | V +40.8pp |
| Operating income | 59.12%$6.9B | 14.02%$89M | V +45.1pp |
| Pre-tax income | 58.74%$6.8B | 13.67%$87M | V +45.1pp |
| Net income |
| 48.38%$5.6B |
| 10.85%$69M |
| V +37.5pp |
No disclosed counterparties: EXLS.
None